Your session is about to expire
← Back to Search
Other
Surgeon-palliative care team co management for Gastrointestinal Cancer (PERIOP-PC Trial)
N/A
Waitlist Available
Led By Rebecca A. Aslakson, MD, Ph.D
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 weeks after surgery
Awards & highlights
PERIOP-PC Trial Summary
This trial will compare two ways of managing care for patients with cancer who are about to have major surgery. One way is for the surgeon to work alone. The other way is for the surgeon to work with a palliative care team. The study will also look at how these two ways of managing care affect the people involved.
Eligible Conditions
- Gastrointestinal Cancer
PERIOP-PC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 12 weeks after surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 weeks after surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Patient quality of life
Secondary outcome measures
Caregiver burden measurement
Caregiver mood symptom assessment
Caregiver prognostic awareness assessment
+6 morePERIOP-PC Trial Design
2Treatment groups
Experimental Treatment
Group I: Surgeon-palliative care team co-managementExperimental Treatment1 Intervention
In the Surgeon-palliative care team co-management arm, all patients receive the surgical care of surgeon alone management, which includes surgeon and the surgical team. In addition to this surgeon alone care, palliative care will also be provided by a specialist team. For patients in this arm, patients and/or family members will be seen by the palliative care team: (1) in an outpatient setting prior to surgery, (2) in the hospital within 72 hours of their initial surgery and as needed afterwards, and (3) via phone on in-clinic (per patient preference) on an at least monthly basis and/or as needed for 12 weeks following surgery.
Group II: Surgeon alone managementExperimental Treatment1 Intervention
The surgeon and surgical team will manage symptoms, psychosocial support, and prognostic related communication. The surgeon and surgical team care for the patient and their family both prior to and following surgery. The surgeon team is given guidelines published by the National Cancer Coalition Network as to when palliative care specialist consultation is recommended
Find a Location
Who is running the clinical trial?
Patient-Centered Outcomes Research InstituteOTHER
550 Previous Clinical Trials
29,996,570 Total Patients Enrolled
Stanford UniversityLead Sponsor
2,390 Previous Clinical Trials
17,340,349 Total Patients Enrolled
Rebecca A. Aslakson, MD, Ph.DPrincipal InvestigatorStanford University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had surgery for upper gastrointestinal cancer to remove the tumor and the goal of the surgery was to cure the cancer, not just relieve the symptoms.
Research Study Groups:
This trial has the following groups:- Group 1: Surgeon alone management
- Group 2: Surgeon-palliative care team co-management
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger